Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
42%
ALSO IN PBE
PBE
27
HOLDINGS
37%
ALSO IN BBH
SECTOR DRIFT (BBH minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 6.3% | 7.4% | 6.3% |
|
GILEAD SCIENCES INC | 12.7% | 5.2% | 5.2% |
|
AMGEN INC | 15.2% | 5.1% | 5.1% |
|
VERTEX PHARMACEUTICALS INC | 8.6% | 4.2% | 4.2% |
|
ILLUMINA INC | 2.9% | 5.8% | 2.9% |
BBH Overweight Relative to PBE
|
AMGEN INC | 10.2% |
|
GILEAD SCIENCES INC | 7.5% |
 |
ARGENX SE ADR | 5.3% |
|
REGENERON PHARMACEUTICALS | 5.3% |
|
IQVIA HOLDINGS INC | 5.0% |
|
VERTEX PHARMACEUTICALS INC | 4.4% |
|
INSMED INC | 4.4% |
|
NATERA INC | 4.1% |
 |
ICON PLC | 3.6% |
|
BIOGEN IDEC INC | 3.5% |
BBH Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -5.3% |
|
UNITED THERAPEUTICS CORP | -4.7% |
|
ANAVEX LIFE SCIENCES CORP. | -3.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.5% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.3% |
|
BIOMARIN PHARMACEUTICAL INC | -3.2% |
|
HALOZYME THERAPEUTICS INC | -3.2% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.1% |
|
AMICUS THERAPEUTICS INC | -3.1% |
|
ACADIA PHARMACEUTICALS INC | -3.0% |